CD274 and neoplasm: In RCC patients, PD-L1 expressed on tumor cells detected by immunohistochemistry was considered to be a risk factor for prognosis, but other studies found that higher PD-L1 mRNA level in RCC tissues estimated by RNA-seq approach was recognized as an indicator of favorable prognosis [7–12].